Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

Results 1-10 of 23
Item hits:
Issue DateTitleAuthor(s)
8-Jan-2019Clinical profile of predefined asthma phenotypes in a large cohort of UK primary care patients (Clinical Practice Research Datalink)Nissen, F; Douglas, I; Mullerova, H; Pearce, N; Bloom, C, et al
1-Jan-2019Risk factors and secondary care utilisation in a primary care population with nontuberculous mycobacterial disease in the UKAxson, E; Bual, N; Bloom, C; Quint, J; Insmed Limited
29-Jan-2019Changing causes of death for chronic respiratory disease patients in England, 2005-2015Gayle, A; Axson, E; Bloom, C; Navaratnam, V; Quint, J
8-Apr-2019Prevalence of breathlessness and associated consulting behaviour: results of an online surveyElbehairy, A; Quint, J; Rogers, J; Laffan, M; Polkey, M, et al
27-Mar-2019The REal Life EVidence AssessmeNt Tool (RELEVANT): development of a novel quality assurance asset to rate observational comparative effectiveness research studiesCampbell, J; Perry, R; Papadopoulos, N; Krishnan, J; Brusselle, G, et al
5-Apr-2019Predicting COPD one year mortality using prognostic predictors routinely measured in primary careBloom, C; Ricciardi, F; Smeeth, L; Stone, P; Quint, J, et al
18-Apr-2019Identifying clinically important COPD sub-types using data-driven approaches in primary care population based electronic health recordsPikoula, M; Quint, J; Nissen, F; Hemingway, H; Smeeth, L, et al
1-Feb-2019Pharmacological treatment of asthma in a cohort of adults during a 20-year period: results from the European Community Respiratory Health Survey I, II and IIIJanson, C; Accordini, S; Cazzoletti, L; Cerveri, I; Chanoine, S, et al
20-Feb-2019Protocol for a systematic literature review and network meta-analysis of the clinical benefit of inhaled maintenance therapies in chronic obstructive pulmonary disease (COPD)Lewis, A; Axson, E; Potts, J; Tarnowska, R; Vioix, H, et al
27-Mar-2019Quality standards in respiratory real-life effectiveness research: The REal Life EVidence AssessmeNt Tool (RELEVANT). Report from the Respiratory Effectiveness Group – European Academy of Allergy and Clinical Immunology Task ForceRoche, N; Campbell, J; Krishnan, J; Brusselle, G; Chisholm, A, et al